LCTX

Lineage Cell Therapeutics Inc

1.00

Oct 23 • 3:59 PM ET +0.01 (1.52%)

0.9960

Aftermarket • 7:53 PM ET -0.0040 (-0.40%)

Healthcare Biotechnology USA Micro AMEX

Peers: IPSC NGEN CAPR IRD MESO OCGN SANA ANNX FATE EYPT

| Held by: VTI IWM VXF IWO IBB VTWO IWC GSSC BUSM VTWG

Scroll to Statements

Index	RUT
Market Cap	252.91M
Enterprise Value	203.26M
Income	-32.26M
Sales	13.08M
Book/sh	0.24
Cash/sh	0.20
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	77
IPO	Mar 05, 1992

P/E	-
Forward P/E	-
PEG	-
P/S	19.34
P/B	4.15
P/C	4.98
P/FCF	-
EV/EBITDA	-
EV/Sales	15.54
Quick Ratio	6.61
Current Ratio	6.61
Debt/Eq	0.04
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-0.18
EPS next Y	-0.10
EPS next Q	-0.03
EPS this Y	79.08%
EPS next Y	-65.86%
EPS next 5Y	-
EPS past 3/5Y	-21.30% -14.94%
Sales past 3/5Y	-0.33% 79.88%
EPS Y/Y TTM	23.17%
Sales Y/Y TTM	19.87%
EPS Q/Q	77.21%
Sales Q/Q	-61.34%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	-6.01% -41.97%

Insider Own	24.46%
Insider Trans	0.00%
Inst Own	26.73%
Inst Trans	2.31%
ROA	-32.75%
ROE	-59.03%
ROIC	-51.81%
Gross Margin	93.81%
Oper. Margin	-205.23%
Profit Margin	-246.58%
SMA20	4.41%
SMA50	-2.12%
SMA200	-25.58%
Trades

Shs Outstand	252.91M
Shs Float	191.06M
Short Float	15.23%
Short Ratio	23.41
Short Interest	29.09M
52W High	2.09 -52.15%
52W Low	0.88 13.34%
Volatility	6.64% 6.99%
ATR (14)	0.06
RSI (14)	52.20
Beta	1.70
Rel Volume	0.93
Avg Volume	1.24M
Volume	1,150,719

Perf Week	2.22%
Perf Month	5.51%
Perf Quarter	-2.91%
Perf Half Y	-35.48%
Perf YTD	-40.12%
Perf Year	-38.65%
Perf 3Y	-13.79%
Perf 5Y	-57.45%
Perf 10Y	-63.03%
Recom	1.43
Target Price	5.50
Prev Close	0.99
Price	1.00
Change %	1.52%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-28-26	Initiated	Canaccord Genuity	Buy	$9
Aug-20-24	Initiated	Craig Hallum	Buy	$4
Nov-02-22	Initiated	Robert W. Baird	Outperform	$5
Jun-14-22	Initiated	B. Riley Securities	Buy	$4
Aug-19-21	Initiated	Noble Capital Markets	Outperform	$8
Mar-31-21	Initiated	Cantor Fitzgerald	Overweight	$6

Sep-08-26 08:00AM	Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE 5D Manufacturing Platform (Business Wire)
Aug-07-26 01:12AM	Lineage Cell Therapeutics Inc (LCTX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended, ... (GuruFocus.com)
Aug-06-26 04:42PM	Lineage Cell: Q2 Earnings Snapshot (Associated Press)
04:01PM	Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update (Business Wire)
Jul-30-26 08:00AM	Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026 (Business Wire)
08:00AM	Loading…
Jul-13-26 08:00AM	Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease (Business Wire) -5.47%
Jul-06-26 08:00AM	Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit (Business Wire)
May-20-26 09:50AM	Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets (PR Newswire) +7.50%
May-13-26 01:02AM	Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
May-12-26 04:07PM	Lineage Cell: Q1 Earnings Snapshot (Associated Press)
04:01PM	Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update (Business Wire)
May-05-26 08:00AM	Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026 (Business Wire)
May-04-26 08:00AM	OpRegen 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026 (Business Wire) -7.19%
Apr-13-26 08:00AM	Lineage Announces Formation of Scientific Advisory Board (Business Wire)
Apr-10-26 09:55AM	Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells (PR Newswire)
08:00AM	Loading…
Mar-24-26 08:00AM	Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease (Business Wire)
Mar-18-26 10:00AM	A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. (PR Newswire) -5.06%
Mar-06-26 05:47AM	Lineage Cell Therapeutics Q4 Earnings Call Highlights (MarketBeat)
Mar-05-26 05:30PM	Lineage Cell (LCTX) Reports Break-Even Earnings for Q4 (Zacks) -5.64%
04:01PM	Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (Business Wire)
Mar-03-26 09:15AM	Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-26-26 05:30PM	Pacira (PCRX) Lags Q4 Earnings and Revenue Estimates (Zacks)
08:00AM	Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 (Business Wire)
Jan-29-26 01:31PM	Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration (PR Newswire)
Dec-16-25 11:53AM	Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy (PR Newswire)
Nov-07-25 12:01AM	Lineage Cell Therapeutics Inc (LCTX) Q3 2025 Earnings Call Highlights: Strategic Partnerships ... (GuruFocus.com)
Nov-06-25 05:20PM	Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:13PM	Lineage Cell: Q3 Earnings Snapshot (Associated Press Finance)
Oct-10-25 09:57AM	Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength? (Zacks) -5.14%
Sep-29-25 12:56AM	HC Wainwright Affirms Buy Rating on Lineage Cell Therapeutics Inc. (LCTX) amid Type 1 Diabetes Push (Insider Monkey)
07:23PM	Loading…
Sep-23-25 07:23PM	Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial (Insider Monkey)
Aug-13-25 03:12AM	Lineage Cell Therapeutics Inc (LCTX) Q2 2025 Earnings Call Highlights: Strategic Partnerships ... (GuruFocus.com)
Aug-12-25 05:10PM	Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:09PM	Lineage Cell: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update (Business Wire)
Aug-07-25 08:45AM	Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Aug-06-25 06:05PM	Brookdale Senior Living (BKD) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-05-25 08:00AM	Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025 (Business Wire)
Aug-04-25 08:00AM	Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury (Business Wire)
Jul-02-25 05:41AM	Lineage Cell Therapeutics unveils promising Phase I/IIa OpRegen results at CTS 2025 (Clinical Trials Arena) +13.62%
Jun-23-25 07:00AM	OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025 (Business Wire)
Jun-05-25 08:00AM	Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium (Business Wire)
May-14-25 11:39AM	Q1 2025 Lineage Cell Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
08:00AM	Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC (Business Wire)
03:14AM	Lineage Cell Therapeutics Inc (LCTX) Q1 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
May-13-25 05:10PM	Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update (Business Wire)
May-12-25 05:45PM	Editas Medicine (EDIT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +8.89%
08:00AM	RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025 (Business Wire)
May-01-25 08:00AM	Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025 (Business Wire)
Apr-22-25 08:00AM	Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium (Business Wire) +7.45%
Apr-21-25 08:00AM	Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO) (Business Wire)
Mar-11-25 11:12AM	Q4 2024 Lineage Cell Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
03:02AM	Lineage Cell Therapeutics Inc (LCTX) Q4 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Mar-10-25 05:25PM	Lineage Cell (LCTX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (Business Wire)
Mar-05-25 08:00AM	Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025 (Business Wire)
Feb-12-25 05:37AM	Lineage begins study of OPC1 delivering device for spinal cord injury treatment (Medical Device Network)
Feb-11-25 08:00AM	Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury (Business Wire)
Feb-04-25 08:00AM	Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference (Business Wire)
Jan-30-25 12:00PM	Lineage Cell (LCTX) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Jan-27-25 04:05PM	Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering (Business Wire)
Jan-06-25 08:00AM	Lineage Cell Therapeutics Issues Letter to Stockholders (Business Wire) -6.90%
Jan-04-25 08:10AM	Lineage Cell price target lowered to $2 from $3 at D. Boral Capital (TipRanks)
Dec-17-24 09:35AM	Down -43.14% in 4 Weeks, Here's Why Lineage Cell (LCTX) Looks Ripe for a Turnaround (Zacks)
Dec-03-24 02:55AM	Is Lineage (LINE) the Best New Pick in Brad Gerstners Portfolio? (Insider Monkey) -7.10%
Nov-21-24 05:00PM	Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering (Business Wire) -6.45% -16.02%
09:35AM	Lineage Cell (LCTX) Loses -26.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-20-24 08:00AM	Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering (Business Wire) -28.99%
Nov-15-24 04:00PM	Lineage Cell Therapeutics Inc (LCTX) Q3 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Nov-14-24 05:15PM	Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update (Business Wire)
Nov-07-24 08:00AM	Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024 (Business Wire)
Oct-14-24 08:00AM	Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit (Business Wire)
Oct-09-24 05:52PM	Lineage Cell Therapeutics Inc (LCTX) Q2 2024 Earnings Call Highlights: Strategic Alliances and ... (GuruFocus.com)
12:00PM	What Makes Lineage Cell (LCTX) a New Buy Stock (Zacks)
Sep-25-24 08:00AM	OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium (Business Wire)
Sep-18-24 08:00AM	Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance, at the 59th Annual Inner Ear Biology Workshop (Business Wire)
Aug-13-24 08:00AM	Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference (Business Wire)
Aug-08-24 06:35PM	Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update (Business Wire)
Aug-01-24 08:00AM	Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 (Business Wire) -6.40%
Jul-02-24 08:00AM	Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index (Business Wire)
May-30-24 08:00AM	Lineage to Present at 2024 BIO International Convention (Business Wire) +6.32%
May-21-24 08:00AM	Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium (Business Wire)
May-10-24 04:40PM	Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript (Insider Monkey) -6.84%
03:49PM	Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines (GuruFocus.com)
02:09PM	Q1 2024 Lineage Cell Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 04:01PM	Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (Business Wire)
May-06-24 08:00AM	OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit (Business Wire) +22.64%
May-02-24 08:00AM	Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 (Business Wire) -7.08%
Apr-30-24 08:00AM	Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) (Business Wire)
Apr-29-24 04:30PM	Lineage Announces Changes to Board of Directors (Business Wire)
Apr-19-24 12:13PM	12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By (Insider Monkey)
Apr-01-24 08:00AM	Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development (Business Wire)
Mar-18-24 10:31AM	15 Best Anti-Aging Foods for Youthful Skin (Insider Monkey) -9.30%
08:00AM	Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium (Business Wire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Culley Brian M	President and CEO	Mar 12 '26	Buy	1.62	15,000	24,375	255,516	Mar 12 04:05 PM

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing cell replacement therapies to treat serious medical conditions. The company's pipeline consists of seven allogeneic cell transplant therapy programs spanning clinical to research stages, targeting a range of conditions including dry-AMD, spinal cord injuries, auditory neuropathy, Type 1 Diabetes, and vision loss, with several programs supported by strategic partnerships with Roche, Genentech, William Demant Invest, and Factor Biosciences. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.

M.B.A.Mr. Brian M. Culley M.A.

Chief Financial OfficerMs. Jill Ann Howe

J.D.Mr. George A. Samuel III

Director of Investor RelationsMs. Ioana C. Hone

Vice President of Corporate Strategy & DevelopmentDr. Charlotte Hubbert Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LCTX

Lineage Cell Therapeutics Inc

Upgrade your Finviz experience